Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Cooperative Growth Study (iNCGS) Post Marketing Surveillance Program for NutropinAq® [Somatropin (rDNA Origin) Injection]

NCT00455728 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00455728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Cooperative Growth Study (iNCGS) Post Marketing Surveillance Program for NutropinAq® [Somatropin (rDNA Origin) Injection]
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
December 31, 2016
Enrollment
3,690 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone disorders